Fusion transcripts involving the same intron of ESR1 are recurrent in breast cancer, and there is evidence they have important functional consequences, largely conferred by the C-terminally truncated estrogen receptor (Li et al., 2013). This evidence concerns the gene ESR1 and breast carcinoma.